Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Symeres logo — Making Molecules Matter. Together.

Symeres

Making Molecules Matter. Together.

Founded 1987 The Netherlands The Netherlands 564 employees Biotechnology, Manufacturing +1

General Information

Company Name Symeres
Founded Year 1987
Location The Netherlands The Netherlands +8
Employees 564
Industries Biotechnology, Manufacturing, Pharmaceutical
Social

Get notified when Symeres moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Symeres

MercachemSyncom is a transatlantic Contract Research Organization specializing in drug discovery and development, with a focus on making molecules matter. The company, founded in 2017, is headquartered in The Netherlands and boasts around 600 highly educated scientists across six locations in Europe and two in the USA. Their expertise spans early stage hit finding to the delivery of early clinical drug substance API. MercachemSyncom positions itself as large enough to matter, yet small enough to care, offering best-in-class solutions for drug discovery and drug development in the Biotechnology, Manufacturing, and Pharmaceutical industries. With a clear slogan of "Making Molecules Matter. Together.", the company blends vast scientific knowledge with inventiveness to make significant strides in the industry. Despite the absence of publicly available information on their last investment and investors, MercachemSyncom's strong foothold in the drug development space and its transatlantic reach make it a compelling candidate for potential venture capital consideration.

Taxonomy: Chemistry, Drug discovery, Contract research organization, European, Nijmegen, Groningen, Prague, Mid-sized organization, Cutting-edge solutions, Chemistry challenges, Chemical research, Netherlands, Czech Republic

No funding data available for Symeres yet.

Get notified when Symeres raises funding

Symeres Alternatives & Competitors

Symeres vs
New England Discovery Partners (NEDP)
New England Discovery Partners (NEDP) United States

Making molecules that matter

5 employees
Biotechnology
Symeres vs
Domainex
Domainex United Kingdom

Enrich your medicines pipeline

Grant
100 employees
Biotechnology, Creator Economy
Symeres vs
Symphony Pharma Life Sciences Private Limited
Symphony Pharma Life Sciences Private Limited India

Chemistry For Humanity

48 employees
Pharmaceutical

FAQ About Symeres

Making Molecules Matter. Together.
Symeres was founded in 1987.
Symeres is headquartered in The Netherlands.
Symeres operates in the following industries: Biotechnology, Manufacturing, Pharmaceutical.
Symeres has approximately 564 employees.
Top alternatives and competitors to Symeres include New England Discovery Partners (NEDP), Domainex, Symphony Pharma Life Sciences Private Limited, Genesis Drug Discovery & Development (GD³), ChemDiv, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Symeres and New England Discovery Partners (NEDP) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Symeres and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy